Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-08-18
1994-04-05
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142282, 5142335, 514255, 514456, 514469, 544 587, 544 62, 544147, 544151, 544153, 544376, 549355, 549398, 549404, 549405, 549408, 549409, 549462, A61K 3134, A61K 3135, C07D30780, C07D31158
Patent
active
053005228
ABSTRACT:
The invention relates to compounds of the formula ##STR1## wherein R.sup.1 is hydrogen. acyl, lower-alkyl or --CHO, --CH.sub.2 OR.sup.10, --COR.sup.7 or OR.sup.13 ; R.sup.2, R.sup.3 and R.sup.4 are, independently, hydrogen, lower-alkyl, lower-alkoxy or halogen; R.sup.5 and R.sup.5 are, independently, hydrogen or lower-alkyl; R.sup.7 is hydroxy, lower-alkoxy or NR.sup.8 R.sup.9 ; R.sup.8 and R.sup.9 are, independently, hydrogen or lower-alkyl; X and Y are, independently, >CR.sup.14 R.sup.15, --O--, --S--, >SO, >SO.sub.2 or >NR.sup.18 ; R.sup.10 and R.sup.18 are, independently, hydrogen, lower-alkyl or acyl; M is --C(R.sup.11).dbd.C(R.sup.12)--, --CONH-- or --NH--CO--; R.sup.11, R.sup.12, R.sup.14 and R.sup.15 are, independently, hydrogen or lower-alkyl, R.sup.13 is hydrogen, lower-alkoxycarbonyl or lower- alkyl, which can be substituted by amino, mono-alkylamino, di-alkylamino, morpholino, thiomorpholino or piperazino; and n is 1, 2, 3 or 4; with the proviso that at least one of X and Y comprises a hetero atom and that n is 1, 3 or 4 when X contains a hetero atom, Y is >C(CH.sub.3).sub.2 and R.sup.1 is lower-alkyl or --CH.sub.2 OR.sup.10 or --COR.sup.7, or a salt of a compound of formula I, when R.sup.1 is carboxy.
The compounds of formula I are useful in the treatment and prophylaxis of neoplasms, dermatoses and ageing of the skin.
REFERENCES:
patent: 3635941 (1972-01-01), Weaver et al.
patent: 4678793 (1987-07-01), Klaus et al.
patent: 4808597 (1989-02-01), Hoffman et al.
patent: 4826984 (1984-05-01), Berlin et al.
Mentzer et al, Chemical Abstracts, vol. 66 (1967) 18193n.
Ohsumi et al, Chemical Abstracts, vol. 112 (1990) 50495s.
R. S. Tewari et al., Chemical Abstracts, 84:73777c, p. 406 (1976).
R. Sahdev et al., Chemical Abstracts, 84:150546f, p. 541 (1976).
D. T. Witiak et al., Journal of Organic Chemistry, 38 (9), pp. 1242-1247 (1974).
H. Hirose, Chemical Abstracts, 105: 235743v, p. 595 (1986).
K. Berlin et al., Chemical Abstracts, 111:173986q, p. 713 (1989).
Y. P. Talwar et al., Chemical Abstracts, 70 77526d, p. 299 (1969).
G. Savona et al., J. Heterocyclic Chem., 8, pp. 681-684 (1971).
M. Botta et al., Tetrahedron Letters, 29 (22), pp. 2741-2744 (1988).
V. S. Fedorov et al Chemical Abstracts, 83: 97106b, p. 574 (1975).
Klaus Michael
Mohr Peter
Weiss Ekkehard
Epstein William H.
Gould George M.
Hoffmann-La Roche Inc.
Pokras Bruce A.
Raymond Richard L.
LandOfFree
Condensed heterocyclic compounds and pharmaceutical use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Condensed heterocyclic compounds and pharmaceutical use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Condensed heterocyclic compounds and pharmaceutical use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-511324